COVID-19 Testing - Global Strategic Business Report

The global market for COVID-19 Testing is estimated at US$19.9 Billion in 2023 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of -16.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the COVID-19 testing market is driven by several factors, including technological advancements, government policies, and changes in consumer behavior. Technological innovations have led to the development of faster, more accurate tests that can be deployed at scale, which are essential for managing outbreaks and facilitating safe social interactions. Government policies and funding have significantly influenced the market, with massive investments in testing infrastructure to support public health strategies. Additionally, public awareness and behavior have changed markedly during the pandemic; there is now a higher demand for personal health monitoring and preventive practices, which includes regular COVID-19 testing. This shift has encouraged continuous growth in the testing market, ensuring that it remains a critical component of global health.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the RT-PCR Assay Kits segment, which is expected to reach US$3.9 Billion by 2030 with a CAGR of a -16.9%. The Immunoassay Test Strips/Cassettes segment is also set to grow at -14.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $5.0 Billion in 2023, and China, forecasted to grow at an impressive -31.0% CAGR to reach $56.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global COVID-19 Testing Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global COVID-19 Testing Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global COVID-19 Testing Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Adaltis Srl, Alfa Scientific Designs, Inc., A*STAR Experimental Therapeutics Centre, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 547 Featured):

• Adaltis Srl
• Alfa Scientific Designs, Inc.
• A*STAR Experimental Therapeutics Centre
• AITbiotech Pte., Ltd.
• Altimmune, Inc.
• ADS Biotec, Inc.
• Accelerate Diagnostics, Inc.
• AccuBioTech Co., Ltd.
• Access Bio, Inc.
• Abwiz Bio Inc.
• AB Diagnostic Systems GmbH
• 1drop, Inc.
• 3B BlackBio Biotech India Ltd.
• Abacus Diagnostica Oy
• Aldatu Biosciences